Parkinson's Disease
Parkinson's Disease screening by GIA®, powered by digitalhumanOS™, uses Voice AI, Computer Vision, and Speech Biomarkers to detect parkinson's disease through a single patient conversation. Screening performance: AUC 0.97 — peer-reviewed. Screening takes under 5 minutes with results in 60 seconds.
Early Parkinson's detection allows for timely intervention, slowing disease progression and improving quality of life.
Parkinson's screening enables proactive care planning in post-acute settings. By identifying the disease early, we can provide targeted therapy and improve motor function.
Key Facts
- Screening Time
- Under 5 minutes
- Results
- 60 seconds
- Modalities
- Voice + Vision + Speech
- Registration
- 510(k)
- Status
- Live
About Parkinson's Disease screening.
How does the system detect Parkinson's disease?
The system analyzes speech patterns, vocal characteristics, and motor skills to assess for Parkinson's markers.
What is the value of early detection for Parkinson's patients?
Early detection allows for access to available treatments, participation in clinical trials, and improved management of symptoms.
What is the AUC for the Parkinson's Disease detection?
The AUC for the Parkinson's Disease detection is 0.97.
The science behind Parkinson's Disease screening.
Research conducted with Beth Israel Deaconess Medical Center and UMass Chan Medical School achieves AUC 0.97 for Parkinson's detection from conversational speech — using natural, unconstrained speech without specialized equipment.
Advancing Parkinson's Detection with Vocal Biomarkers and Speech Foundation Models (2025-08) · Beth Israel Deaconess Medical Center, UMass Chan Medical School